Health Press Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Bhutan.

Press releases published on November 2, 2026

6 hours ago

Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data

Indeterminate GlobeNewswire

6 hours ago

Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.

Indeterminate GlobeNewswire

6 hours ago

Eyconis to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026

Indeterminate GlobeNewswire

6 hours ago

Humacyte To Announce 2026 Third Quarter Financial Results and Provide Business Update on November 10, 2026

Indeterminate GlobeNewswire

6 hours ago

New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation

Indeterminate GlobeNewswire

6 hours ago

Theriva™ Biologics anuncia la venta de SYN-004 (ribaxamasa) y la cartera de enzimas degradadoras de antibióticos asociada a Biossil Labs Inc.

Indeterminate GlobeNewswire

6 hours ago

CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer

Indeterminate GlobeNewswire

6 hours ago

AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry

Indeterminate GlobeNewswire

6 hours ago

Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study

Indeterminate GlobeNewswire

6 hours ago

Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China

Indeterminate GlobeNewswire

6 hours ago

UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Indeterminate GlobeNewswire

6 hours ago

Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets

Indeterminate GlobeNewswire

6 hours ago

Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

6 hours ago

Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective

Indeterminate GlobeNewswire

6 hours ago

Lyell Immunopharma To Participate in November Investor Events

Indeterminate GlobeNewswire

6 hours ago

Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response

Indeterminate GlobeNewswire

6 hours ago

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

6 hours ago

Crescent Biopharma to Present at November Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Cognition Therapeutics to Host Third Quarter 2026 Financial Results and Business Update Call on November 5, 2026

Indeterminate GlobeNewswire